NASDAQ: ERAS - Erasca, Inc.

Yield per half year: +47.03%
Sector: Healthcare

Share chart Erasca, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Erasca, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на обнаружении, разработке и коммерциализации методов лечения пациентов с раком, управляемым путем RAS / MAPK. Его главные кандидаты включают ERAS-007, пероральный ингибитор ERK1 / 2 для лечения NSCLC, колоректального рака и острого миелоидного лейкоза; и ERAS-601, пероральный ингибитор SHP2 для пациентов с запущенными или метастатическими солидными опухолями. Компания была зарегистрирована в 2018 году, ее штаб-квартира находится в Сан-Диего, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Число акций ао 0.15018 млрд
EV/EBITDA 1.99
EBITDA -0.013
Цена ао 2.72
Сайт http://www.erasca.com
P/BV 4.06
ISIN US29479A1088
Валюта usd
IPO date 2021-07-16
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: -2.86% (2.8)
Change price per week: +6.25% (2.56)
Change price per month: -5.88% (2.89)
Change price per 3 month: -7.8% (2.95)
Change price per half year: +47.03% (1.85)
Change price per year: +21.97% (2.23)
Change price per 3 year: -85.88% (19.26)
Change price per year to date: +21.43% (2.24)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.03 9
P/E 0 0
EV/EBITDA -2.1 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -31.63 0
ROE, % -39.48 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4054 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 959.95 10
Yield EPS, % 362.55 10
Total: 8
More

Institutions Volume Share, %
Arch Venture Management, Llc 11 6.38
Blackrock Inc. 7 4.03
Armistice Capital, LLC 6 3.56
Artal Group S.A. 5 2.72
Vanguard Group Inc 4 2.5
Prosight Management, LP 4 2.11
Ah Capital Management, L.L.C. 3 1.65
PFM Health Sciences, LP 3 1.46
Sio Capital Management, LLC 2 1.4
Bank of America Corporation 2 1.27

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis U.S Small Cap Equity ETF 0.05731 35.517080018718 1.68271
Avantis U.S. Equity ETF 0.0004 37.016870113839 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 1.04981 77.329244365683 0.33
ProShares Ultra Nasdaq Biotechnology 0.0499 58.954326923077 0.85651
Range Cancer Therapeutics ETF 1.89878 58.680203045685 0.11955
Dimensional U.S. Core Equity 2 ETF 0.00032 37.528779739064 1.47098
Dimensional U.S. Targeted Value ETF 0.00192 32.980877390326 1.93487
Dimensional US Core Equity Market ETF 0.00048 35.65815324165 1.40618
Dimensional U.S. Equity ETF 0.00096 36.134982184029 1.3557
Fidelity MSCI Health Care Index ETF 0.00719 21.181088923024 1.46057
Goldman Sachs Innovate Equity ETF 0.05299 36.115879828326 1.20987
ProShares Hedge Replication ETF 0.00199 6.8665973306333 1.47892
Invesco Nasdaq Biotechnology ETF 0.07437 29.399255715045 0.8565
iShares Micro-Cap ETF 0.12998 43.316995205115 1.54048
iShares Russell 3000 ETF 0.00132 37.942616648456 1.43482
Schwab U.S. Small-Cap ETF 0.01407 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.00089 -53.970149253731 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00322 29.55850326668 2.19607
ProShares UltraPro Russell2000 0.00704 125.96465921385 1.47873
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 ETF 0.01 41.410408042578 1.48801
Principal Healthcare Innovators ETF 0.07922 631.79771324797 0.8416
Future Tech ETF 0.07922 412.888593871 0.8416



Head Job title Payment Year of birth
Dr. David M. Chacko M.D. CFO & Chief Business Officer 616.76k 1984 (40 years)
Dr. Michael D. Varney Ph.D. Chairman of Research & Development, Scientific Advisory Board Member and Director 83.26k 1958 (66 years)
Dr. Nik Chetwyn Ph.D. Chief Operating Officer N/A
Dr. Lisa Tesvich-Bonora Ph.D. Chief People Officer N/A
Dr. Robert Shoemaker Ph.D. Senior Vice President of Research N/A 1981 (43 years)
Dr. Jonathan E. Lim M.D. Co-Founder, Chairman & CEO 940.32k 1972 (52 years)
Ms. Chandra D. Lovejoy M.S. Chief Regulatory Affairs Officer N/A 1971 (53 years)
Dr. Shannon R. Morris M.D., Ph.D. Chief Medical Officer N/A 1970 (54 years)
Mr. Brian L. Baker CPA, M.S. Senior Vice President of Finance N/A 1967 (57 years)
Mr. Ebun S. Garner Esq., J.D. General Counsel & Corporate Secretary 1972 (52 years)

Address: United States, San Diego, CA , 10835 Road to the Cure - open in Google maps, open in Yandex maps
Website: http://www.erasca.com